ANDA 215791, held by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Degarelix Acetate.
As of Nov 16, 2026, ANDA 215791 (Degarelix Acetate), held by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 18, 2025 | Original application | Tentative approval | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Degarelix Acetate80MG ยท njection, powder, lyophilized, for solution | Degarelix Acetate | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters